Cart
sales@molnova.com
RS 25344 hydrochloride
CAS No. 152815-28-6
RS 25344 hydrochloride( —— )
Catalog No. M23660 CAS No. 152815-28-6
RS 25344 hydrochloride is a phosphodiesterase (PDE) 4 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 72 | In Stock |
|
| 10MG | 115 | In Stock |
|
| 25MG | 260 | In Stock |
|
| 50MG | 410 | In Stock |
|
| 100MG | 605 | In Stock |
|
| 500MG | 1287 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRS 25344 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionRS 25344 hydrochloride is a phosphodiesterase (PDE) 4 inhibitor.
-
DescriptionRS 25344 hydrochloride is a phosphodiesterase (PDE) 4 inhibitor.
-
In VitroRS-25344 hydrochloride (0-10 μM) is a potent inhibitor of sperm PDE activity, with an effective concentration of 0.3 nM and reaching maximum inhibition in the range of 100 nM.
-
In VivoRS-25344 hydrochloride (5 mg/kg; i.p.; twice daily for 72 h) results in significant increases in stomach weights in wild type C57BL/6 mice. RS-25344 hydrochloride (1 mg/kg; i.p.; 30 min prior to food bolus) increases gastric retention in mice.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
Recptorphosphodiesterase (PDE) 4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number152815-28-6
-
Formula Weight411.8
-
Molecular FormulaC19H14ClN5O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:80mg/ml(194.27mM; need ultrasonic)
-
SMILESO=C1N(C2=CC=CC([N+]([O-])=O)=C2)C3=NC=CC=C3C(N1CC4=CC=NC=C4)=O.[H]Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CHF6001
A novel, highly potent and selective phosphodiesterase 4 (PDE4) inhibitor with IC50 of 0.026 nM.
-
WAY-313170
WAY-313170 Inhibits hedgehog signaling and phosphodiesterase.
-
OPC18750 HCl
OPC18750 HCl is a potential phosphodiesterase inhibitor with positive inotropic effects that can be used to study asthma, cancer, diabetes, and psychiatric disorders.
